Hong Kong (HQ)ShanghaiZurichChicago
HKG time - 14:32 HKTLinkedIncontact@visionlifesciences.com

Biotech Consulting & Cross-Border Pharma Advisory.

Life science consulting for licensing, M&A, partnerships, and deal-making across global pharma and biotech.

Contact us
Partner-led engagementsNDA-first conversationsResponse within 24 hours
Network
Three continents
Hong Kong · Shanghai · Zurich · Chicago
Mandates
Buy and sell side
Licensing · Partnerships · NewCo
Experience
Decades
Pharma and biotech business development
Opportunities
Billions
In transaction value sourced and evaluated

Our view

The next decade of medicine will be written by partnerships that move across borders, not within them.

House view · Vision Lifesciences

Services

Strategic advisory across the full deal lifecycle.

Every mandate is led by a senior partner with first-hand experience across Asia, Europe and North America. We work selectively, with a focused team, from sourcing to signing.

All services

  • 01

    In-licensing

    Acquire rights to innovative therapeutics and technologies from global sources.

    Asset sourcing · Scientific diligence · Deal execution

    View service: In-licensing

  • 02

    Out-licensing

    Represent differentiated programmes to qualified strategic buyers and partners.

    Buyer mapping · Package preparation · Terms negotiation

    View service: Out-licensing

  • 03

    Strategic partnerships

    Build alliances for development, manufacturing and commercialisation.

    Co-development · Cross-border manufacturing · Joint commercialisation

    View service: Strategic partnerships

  • 04

    NewCo formation

    Spin assets into independent companies with global capital and dedicated focus.

    Carve-out structuring · Capital syndication · Governance design

    View service: NewCo formation

Therapeutic focus

Where our network runs deepest.

We advise across modalities and indications. These are the areas where our cross-border relationships, scientific depth and recent deal flow are most concentrated.

Why Vision Lifesciences

A specialist advisor for life-science deal-making.

Decades of combined experience in pharma and biotech business development, and a network across three continents.

  • 01

    Global network

    Direct relationships with biotechs, academic institutions and pharma across Asia, Europe and North America.

  • 02

    Asset expertise

    Scientific, commercial, regulatory and IP evaluation across modalities and indications.

  • 03

    Deal experience

    A multi-decade record of cross-border life-science mandates across licensing, partnerships and NewCo formation.

  • 04

    End-to-end support

    From sourcing and diligence through negotiation, signing and integration.

Footprint

One firm. Four teams.

Senior coverage in every region and the same partners on every mandate.

TeamRegionLocal time
Hong KongHeadquarters · Asia-Pacific
ShanghaiGreater China
ZurichEurope
ChicagoAmericas
A stone-paved square in the morning

Scope of engagement

Services
Licensing · Partnerships · NewCo
Buy-side and sell-side, end to end.
Therapeutic areas
Oncology · Immunology · Metabolic · CNS · Rare
Modality-agnostic, from small molecules to cell and gene.
Deal size
$25M to $1B+
In committed economics, with bespoke structures.
Typical timeline
4 to 9 months
From term sheet to close, partner-led throughout.

Insights

Selected thinking from the desk.

All insights

Begin a confidential conversation.

Tell us what you are working on. We reply within one business day, and we can sign an NDA before you share any materials.

Arrange a private introduction
contact@visionlifesciences.com